Penzberg, Germany

Ralf Schumacher

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 165(Granted Patents)


Company Filing History:


Years Active: 2002-2023

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: Innovations and Contributions of Ralf Schumacher in Biomedicine

Introduction:

Ralf Schumacher, a prominent inventor based in Penzberg, Germany, has made significant strides in the field of biomedicine through his innovative inventions. With a remarkable portfolio of 26 patents, he is recognized for contributions that have the potential to revolutionize therapeutic approaches.

Latest Patents:

Among his latest innovations, Ralf Schumacher has developed glycosylated antibodies, offering novel compositions that comprise human IgG1 or IgG3 heavy chain constant domains. These antibodies are distinguished by a sugar chain at Asn297, characterized by a high fucose content of at least 99%, and minimal amounts of NGNA (1% or less) and N-terminal alpha 1,3 galactose (1% or less). The therapeutic uses of these antibodies underscore their potential impact in treating various conditions. Furthermore, he has introduced bispecific antibodies and methods of use in ophthalmology, which specifically bind to two different antigens such as human ANG2, human VEGF, human IL-1beta, and human PDGF-B, enhancing targeted treatment strategies in this field.

Career Highlights:

Throughout his career, Ralf Schumacher has showcased his expertise while working with renowned organizations such as Hoffmann-La Roche Inc. and Roche Palo Alto LLC. His work has consistently emphasized the intersection of scientific research and practical application, establishing him as a significant figure in the patent landscape of biomedicine.

Collaborations:

Collaboration has been key in Ralf Schumacher's journey as an inventor. He has collaborated with prominent professionals like Stefan Seeber and Yvo Graus, fostering an environment of innovation that has led to the development of groundbreaking therapeutic solutions.

Conclusion:

Ralf Schumacher's extensive patent portfolio and innovative contributions exemplify the transformative potential of biomedicine. His work not only showcases his ingenuity but also highlights the importance of collaboration and research in advancing health care solutions. With a focus on bispecific antibodies and glycosylated antibodies, his inventions stand to shape the future of therapeutic interventions effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…